Epitopes derived from satb2 and uses thereof
AssigneeAtlas Antibodies AB
InventorsKarin Jirsrtöm, Fredrik Pontén, Mathias Uhlén
Life of this patent
Estimating the term…
Abstract
The present invention relates to an affinity ligand capable of selective interaction with an epitope sequence consisting of 47 amino acids or less and comprising the amino acid sequence of SEQ ID NO:1 and/or SEQ ID NO:2. Further, it relates to a polypeptide consisting of the epitope sequence and to uses of the affinity ligand and the polypeptide.
Claims21
1-96. (canceled)
Affinity ligand capable of selective interaction with an epitope sequence consisting of 47 amino acids or less and comprising the amino acid sequence of SEQ ID NO:1.
An isolated polypeptide consisting of 47 acid residues or less and comprising the amino acid sequence of SEQ ID NO:1.
Method of preparing an antibody, comprising an immunization in which a polypeptide consisting of 47 acid residues or less and comprising the amino acid sequence of SEQ ID NO:1 is used as an antigen.
Method of selection or purification of an affinity ligand, comprising contacting the affinity ligand with a polypeptide consisting of 47 acid residues or less and comprising the amino acid sequence of SEQ ID NO:1 is used as an antigen.
Dependencies are inferred from the claim text.